rts logo

Surmodics, Inc. (SRDX) Stock Could Soon Reward Patient Investors

Surmodics, Inc. (NASDAQ: SRDX) is 9.02% higher on its value in year-to-date trading and has touched a low of $25.17 and a high of $42.44 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SRDX stock was last observed hovering at around $39.67 in the last trading session, with the day’s loss setting it -0.04%.

Currently trading at $39.63, the stock is -1.55% and -3.85% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.18 million and changing -0.10% at the moment leaves the stock 12.97% off its SMA200. SRDX registered 4.68% gain for a year compared to 6-month gain of 23.57%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -4.07% loss in the last 1 month and extending the period to 3 months gives it a -5.78%, and is -0.20% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.71% over the week and 0.85% over the month.

Surmodics, Inc. (SRDX) has around 376 employees, a market worth around $565.52M and $120.82M in sales. Profit margin for the company is -1.16%. Distance from 52-week low is 57.45% and -6.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.93%).

The EPS is expected to shrink by -479.69% this year.

Surmodics, Inc. (SRDX) Top Institutional Holders

168.0 institutions hold shares in Surmodics, Inc. (SRDX), with institutional investors hold 97.90% of the company’s shares. The shares outstanding are 14.15M, and float is at 13.65M with Short Float at 3.38%. Institutions hold 94.15% of the Float.

The top institutional shareholder in the company is BERYL CAPITAL MANAGEMENT LLC with over 1.54 million shares valued at $64.83 million. The investor’s holdings represent 10.8962% of the SRDX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 1.17 million shares valued at $$49.22 million to account for 8.2733 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 1.12 million shares representing 7.8864% and valued at over $46.92 million, while TRIGRAN INVESTMENTS, INC. holds 7.3748 of the shares totaling 1.04 million with a market value of $43.88 million.

Surmodics, Inc. (SRDX) Insider Activity

#####

Related Posts